GlucoTrack Stock Overlap Studies Triangular Moving Average
| GCTK Stock | USD 1.21 -0.06 -4.72% |
| Symbol |
This analysis covers thirty-eight data points across the selected time horizon. The Triangular Moving Average shows GlucoTrack double smoothed mean price over a specified number of previous prices (i.e., averaged twice).
GlucoTrack Technical Analysis Modules
Most technical analysis of GlucoTrack help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for GlucoTrack from various momentum indicators to cycle indicators. When you analyze GlucoTrack charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Stock Overview, Methodology & Data Sources
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel. Glucotrack operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 5 people. Downside history and drawdown behavior provide context for risk expectations in GlucoTrack. Past price movements indicate comparatively limited downside dispersion. GlucoTrack has a market cap of 1.22 M, ROE of -14.91%.
Methodology
Unless otherwise specified, financial data for GlucoTrack is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. GlucoTrack (USA Stocks:GCTK) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Inputs are aggregated from public filings and market reference sources and public institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR. Certain values may not reflect real-time changes. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
GlucoTrack may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
This content is curated and reviewed by:
Raphi Shpitalnik - Junior Member of Macroaxis Editorial BoardSome investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards GlucoTrack in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, GlucoTrack's short interest history, or implied volatility extrapolated from GlucoTrack options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Social Domain Invested few shares | |
 | Macroaxis Index Invested over 60 shares | |
 | Dividend Beast Invested over 40 shares | |
 | Momentum Invested few shares | |
 | Hedge Favorites Invested over 20 shares | |
 | Artificial Intelligence Invested few shares | |
 | Data Storage Invested few shares | |
 | Baby Boomer Prospects Invested over 20 shares | |
More Resources for GlucoTrack Stock Analysis
A structured review of GlucoTrack often starts with core financial statements and trend context. Ratio analysis helps investors evaluate GlucoTrack Stock operating efficiency and financial trajectory. Highlighted below are reports that provide context for GlucoTrack Stock:GlucoTrack has a market cap of 1.22 M, ROE of -14.91%. See Risk vs Return Analysis for portfolio-level analysis. This includes a position in GlucoTrack inside the allocation mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.Explore our How to Trade GlucoTrack Stock guide to learn how to trade GlucoTrack effectively.GlucoTrack currently shows ROE of -14.91%, market cap of 1.22 Million. GlucoTrack analysis should be paired with portfolio risk and diversification tools before adjusting allocations. Within the Healthcare space, GlucoTrack peer comparison and risk tools below help frame relative strengths and weaknesses. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
The market value of GlucoTrack is measured differently than book value, which reflects GlucoTrack accounting equity. GlucoTrack's market capitalization is 1.22 M. A P/B ratio of 0.44 suggests GlucoTrack trades near or below book value. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Valuation methods compare these perspectives to frame context.
Note that GlucoTrack's intrinsic value and market price are different measures derived from different inputs. For GlucoTrack, key inputs include a P/B ratio of 0.44, and ROE of -14.91%. GlucoTrack's market quotation reflects the latest level where a willing buyer met a willing seller.